Long-Term Enalapril Therapy for Left Ventricular Dysfunction in Doxorubicin-Treated Survivors of Childhood Cancer
- 1 December 2002
- journal article
- research article
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 20 (23), 4517-4522
- https://doi.org/10.1200/jco.2002.12.102
Abstract
PURPOSE: A common late effect of doxorubicin therapy for childhood cancer is reduced left-ventricular (LV) wall thickness resulting in elevated LV afterload and depressed LV function. Many children...Keywords
This publication has 26 references indexed in Scilit:
- Late Mortality Experience in Five-Year Survivors of Childhood and Adolescent Cancer: The Childhood Cancer Survivor StudyJournal of Clinical Oncology, 2001
- Ventricular dysfunction clinical research in infants, children and adolescentsProgress in Pediatric Cardiology, 2000
- Angiotensin-converting enzyme inhibitor therapy for ventricular dysfunction in infants, children and adolescents: a reviewProgress in Pediatric Cardiology, 2000
- Cancer and Cardiac Mortality Among 15-Year Survivors of Cancer Diagnosed During Childhood or AdolescenceJournal of Clinical Oncology, 1999
- Anthracycline-induced cardiotoxicity in children and young adultsCritical Reviews in Oncology/Hematology, 1998
- Late cardiotoxicity following anthracycline therapy for childhood cancerProgress in Pediatric Cardiology, 1998
- Regression of Cardiac Hypertrophy Normalizes Glucose Metabolism and Left Ventricular Function During ReperfusionJournal of Molecular and Cellular Cardiology, 1997
- Female Sex and Higher Drug Dose as Risk Factors for Late Cardiotoxic Effects of Doxorubicin Therapy for Childhood CancerNew England Journal of Medicine, 1995
- Developmental modulation of myocardial mechanics: Age- and growth-related alterations in afterload and contractilityJournal of the American College of Cardiology, 1992
- Late Cardiac Effects of Doxorubicin Therapy for Acute Lymphoblastic Leukemia in ChildhoodNew England Journal of Medicine, 1991